BPC-157 mastery course
Unit 5 of 12

Gut healing: the original domain

Long before tendons or nerves, BPC-157 was a gut peptide. The Zagreb group first described it protecting the rat stomac…

Where the BPC-157 story actually began

Long before tendons or nerves, BPC-157 was a gut peptide. The Zagreb group first described it protecting the rat stomach lining against chemical and stress injury, then widened the claim to complex defects: colitis, surgical joins of the bowel, and even fistulas, abnormal tunnels between organs. This is the deepest and broadest part of the whole literature.

It is also where the honesty has to be sharpest. Thirty years of mostly rat work, almost all from one lineage, sits behind a single human safety abstract (PL 14736, phase 1) and a phase 2 ulcerative colitis program whose efficacy results were never published. This unit maps what the gut evidence really shows, region by region and tier by tier.

Key terms

A map of the gut claims


Indications versus evidence dimensions


Three decades, from stomach to clinic


PL 14736: what the human trials showed


The gut evidence, tiered